# CRISPR Therapeutics AG (CRSP)

> Healthcare · CH · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CRSP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 11.64M | $ -214.09M | $ -302.95M | $ 783.75M | $ 1.75B |
| 2025 | $ 3.59M | $ -595.51M | $ -354.20M | $ 394.91M | $ 1.92B |
| 2024 | $ 38.49M | $ -384.96M | $ -152.06M | $ 223.69M | $ 1.93B |
| 2023 | $ 400.06M | $ -166.09M | $ -291.77M | $ 238.63M | $ 1.88B |
| 2022 | $ 487.1K | $ -726.31M | $ -595.34M | $ 244.02M | $ 1.88B |
| 2021 | $ 1.09B | $ 448.91M | $ 543.53M | $ 225.03M | $ 2.40B |
| 2020 | $ 916.0K | $ -444.43M | $ -327.05M | $ 61.43M | $ 1.66B |
| 2019 | $ 373.79M | $ 86.30M | $ 64.53M | $ 52.54M | $ 939.43M |
| 2018 | $ 4.13M | $ -217.89M | $ -130.76M | $ 0 | $ 392.20M |
| 2017 | $ 55.23M | $ -92.08M | $ -104.96M | $ 0 | $ 187.83M |
| 2016 | $ 7.10M | $ -31.92M | $ -80.25M | $ 0 | $ 232.85M |
| 2015 | $ 346.8K | $ -35.83M | $ 81.82M | $ 38.34M | $ -29.10M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.45 |
| Liabilities / Eq | 0.52 |
| Current Ratio | 17.85 |

## Other views

- [Metrics](https://sponda.capital/en/CRSP.md)
- [Charts](https://sponda.capital/en/CRSP/charts.md)
- [Compare](https://sponda.capital/en/CRSP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.